Dx Focus: PEPFAR Funding Drives Cepheid TB Test Uptake; Curetis Starts US Trials for MDx System
December 06, 2012
Dx Focus: PEPFAR Funding Drives Cepheid TB Test Uptake; Curetis Starts US Trials for MDx System
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Cepheid Inks First in Series of Agreements to Buy Down Price of Xpert TB Test
August 9, 2012 / PCR Insider - Unitaid Provides $30M to Reduce Cost, Increase Uptake of Cepheid TB Test in Developing World
June 14, 2012 / PCR Insider - Unitaid Provides $30M to Lower Cost of Cepheid TB Test in Developing World
June 14, 2012 / GenomeWeb Daily News - UNC Team Wins NIH Grant to Study Treatment Outcomes of TB Patients Diagnosed with Cepheid Test
April 12, 2012 / PCR Insider - FIND Study Shows Cepheid TB Test Performs Well in Remote Labs, Reduces Time to Treatment
April 21, 2011 / PCR Insider